Author:
Castellano Isabella,Metovic Jasna
Publisher
Springer International Publishing
Reference26 articles.
1. Bartow, S. A., Black, W. C., Waeckerlin, R. W., & Mettler, F. A. (1982). Fibrocystic disease: A continuing enigma. Pathology Annual, 2, 93–111.
2. Boyd, M., Hildebrandt, R. H., & Bartow, S. A. (1996). Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Research and Treatment, 37, 243–251.
3. Castells, X., Domingo, L., Corominas, J. M., Torá-Rocamora, I., Quintana, M. J., Baré, M., Vidal, C., Natal, C., Sánchez, M., Saladié, F., Ferrer, J., Vernet, M., Servitja, S., Rodríguez-Arana, A., Roman, M., Espinàs, J. A., & Sala, M. (2015). Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: A study from a population-based screening program. Breast Cancer Research and Treatment, 149, 237–244.
4. Celis, J. E., Gromova, I., Gromov, P., Moreira, J. M., Cabezón, T., Friis, E., & Rank, F. (2006). Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia. FEBS Letters, 580, 2935–2944.
5. Cserni, G. (2012). Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 120, 249–252.